Development of Solid Self-Emulsifying Formulation for Improving the Oral Bioavailability of Erlotinib

To improve the solubility and oral bioavailability of erlotinib, a poorly water-soluble anticancer drug, solid self-emulsifying drug delivery system (SEDDS) was developed using solid inert carriers such as dextran 40 and Aerosil® 200 (colloidal silica). The preliminary solubility of erlotinib in var...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:AAPS PharmSciTech
Main Authors: Truong, Duy Hieu, Tran, Tuan Hiep, Ramasamy, Thiruganesh, Choi, Ju Yeon, Lee, Hee Hyun, Moon, Cheol, Choi, Han-Gon, Yong, Chul Soon, Kim, Jong Oh
Formato: Artigo
Idioma:Inglês
Publicado: Springer US 2015
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4984901/
https://ncbi.nlm.nih.gov/pubmed/26238806
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1208/s12249-015-0370-5
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares